Spinal Cord Stimulator Market By Type (Rechargeable and Non-Rechargeable), By Application (Degenerative Disk Disease (DDD), Failed Back Syndrome (FBS), Multiple Back Operations, Complex Regional Pain Syndrome (CRPS), and Others), By End User (Hospitals, Clinics, and Ambulatory Surgical Units), Industry Trends, Estimation & Forecast, 2023-2030

Market Definition

Spinal cord stimulator is an implanted device that sends low levels of electricity directly into the spinal cord to relieve pain. Spinal Cord Stimulator (SCS) systems are used most often after nonsurgical pain treatment and to treat chronic pain. The spinal cord stimulator (SCS) system is surgically placed under the skin and sends a mild electric current to the spinal cord.

The Spinal Cord Stimulator market was valued at 3.4 billion US$ in 2022 and is projected to reach 7 billion US$ by 2030, at a CAGR of 9.5% during the forecast period.

Market Dynamics

Rising incidence of chronic pain and neuropathic pain has driven the demand for spinal cord stimulator market. For instance, according to the Centers for Disease Control and Prevention, more than 50 million U.S. adults are suffering from chronic pain, and 19.6 million U.S. adults had high-impact chronic pain in 2018. In Australia, 3.24 million people were living with chronic pain in 2018, and it is expected to be 5.23 million people by 2050. Neuropathic pain is more often occurs in women and patients >50 years of age, and mostly affects the lower back and lower limbs, neck, and upper limbs. According to the International Association for the Study of Pain, in the United States, around 3 million people suffer from neuropathic pain and 7.7 million people in Europe suffered from neuropathic pain sometime in their life. Further, increasing regulatory approval for spinal cord stimulator is a key driving factor of the market. For instance, Nevro has received CE mark approval for its Senza Omnia spinal cord stimulator (SCS) system for the management of chronic pain. Omnia Spinal Cord Stimulation has received FDA approval for chronic pain. The Senza Omnia is the first to deliver all frequencies from 2 to 10,000 Hz, compared to the 1-1,200 Hz range provided by traditional spinal cord stimulator. However, product recall for spinal cord stimulator might hamper market growth. According to the U.S Food and Drug Administration, spinal cord stimulators accounted for the third-highest number of medical device injury. More than 80,000 incidents are reported to the FDA involved spinal-cord stimulators till 2018. Moreover, increasing investment in spinal cord stimulator would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global spinal cord stimulator market is mainly classified based on type, application, and end-user. Type is further segmented into Rechargeable and Non-Rechargeable. By application, the market is divided into Degenerative Disk Disease (DDD), Failed Back Syndrome (FBS), Multiple Back Operations, Complex Regional Pain Syndrome (CRPS), and Others. By end-user, the market is further divided into Hospitals, Clinics, and Ambulatory Surgical Units.

Non-Rechargeable has shown significant growth for spinal cord stimulator market in 2019, due to the increasing commercialization of new spinal cord stimulator, rising investment for R&D activities for spinal cord stimulator, and regulatory approval of non-rechargeable spinal cord stimulator. For instance, Abbott has received the U.S. Food and Drug Administration (FDA) approval for Proclaim XR recharge-free spinal cord stimulation system for people living with chronic pain. Proclaim XR delivers lower doses of spinal cord stimulation (SCS) that helps to extend the battery life, allowing people to experience pain relief process, without recharging, for up to 10 years.

Regional Analysis

Based on geography, the global spinal cord stimulator market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global spinal cord stimulator market in 2019, due to the rising incidence of chronic pain and neuropathic pain, commercialization of regulatory approved spinal cord stimulator system, the collaboration between companies to develop and supply spinal cord stimulator at the global scale, and rising investment for the development of the products. For instance, Saluda Medical Pty Limited has received USD$40 million for R&D activities and commercialization of Evoke. Saluda Medical is developing the first intelligent Evoke Spinal Cord Stimulator (SCS) System. Evoke is designed to use the patient’s neural fingerprint to monitor and adapt the dose of electrical stimulation automatically.

Competitive landscape

Key players operating in the spinal cord stimulator industry include Medtronic, Boston Scientific Corp., St. Jude Medical, Nevro Corp, Nuvectra Corporation, Saluda Medical PTY Limited, Greatbatch, Inc., NeuroPace, Synapse Biomedical, and Stimwave.

Increasing regulatory approval of spinal cord stimulator, the partnership between companies to develop and commercialize new spinal cord stimulator, increasing investment to develop new spinal cord stimulator, increasing research studies on spinal cord stimulator, and the increasing commercialization of new spinal cord stimulator are some of the strategies adopted by major companies. For instance, on January 31, 2019, Boston Scientific has introduced the Spectra WaveWriter spinal cord stimulator (SCS) System in Europe. The Spectra WaveWriter spinal cord stimulator System is used for the treatment of chronic pain with simultaneously combine paresthesia-based and sub-perception therapy.

Spinal Cord Stimulator Market Key Segments:

By Type
• Rechargeable
• Non-Rechargeable

By Application
• Degenerative Disk Disease (DDD)
• Failed Back Syndrome (FBS)
• Multiple Back Operations
• Complex Regional Pain Syndrome (CRPS)
• Others

By End User
• Hospitals
• Clinics
• Ambulatory Surgical Units

Key Global Spinal Cord Stimulator Industry Players
• Medtronic
• Boston Scientific Corp.
• St. Jude Medical
• Nevro Corp
• Nuvectra Corporation
• Saluda Medical PTY Limited
• Greatbatch, Inc.
• NeuroPace
• Synapse Biomedical
• Stimwave

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Spinal Cord Stimulator Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Rising Incidence of Chronic Pain and Neuropathic Pain
3.3.2. Increasing Regulatory Approval for Spinal Cord Stimulator
3.4. Restraints
3.4.1. Product Recall
3.5. Opportunity
3.5.1. Increasing Investment in Spinal Cord Stimulator
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Rechargeable
4.2.1. Market Size & Forecast
4.3. Non-Rechargeable
4.3.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Degenerative Disk Disease (DDD)
5.2.1. Market Size & Forecast
5.3. Failed Back Syndrome (FBS)
5.3.1. Market Size & Forecast
5.4. Multiple Back Operations
5.4.1. Market Size & Forecast
5.5. Complex Regional Pain Syndrome (CRPS)
5.5.1. Market Size & Forecast
5.6. Others
5.6.1. Market Size & Forecast

6. End User Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. Hospitals
6.2.1. Market Size & Forecast
6.3. Clinics
6.3.1. Market Size & Forecast
6.4. Ambulatory Surgical Units
6.4.1. Market Size & Forecast

7. Spinal Cord Stimulator Market Regional Overview
7.1. Introduction
7.1.1. Market Size & Forecast
7.2. North America Spinal Cord Stimulator Market
7.2.1. North America Market Size & Forecast, By Country
7.2.2. North America Market Size & Forecast, By Type
7.2.3. North America Market Size & Forecast, By Application
7.2.4. North America Market Size & Forecast, By End User
7.2.5. U.S.
7.2.5.1. Market Size and Forecast
7.2.6. Canada
7.2.6.1. Market Size and Forecast
7.2.7. Mexico
7.2.7.1. Market Size and Forecast
7.3. Europe Spinal Cord Stimulator Market
7.3.1. Europe Market Size & Forecast, By Country
7.3.2. Europe Market Size & Forecast, By Type
7.3.3. Europe Market Size & Forecast, By Application
7.3.4. Europe Market Size & Forecast, By End User
7.3.5. Germany
7.3.5.1. Market Size and Forecast
7.3.6. France
7.3.6.1. Market Size and Forecast
7.3.7. UK
7.3.7.1. Market Size and Forecast
7.3.8. Italy
7.3.8.1. Market Size and Forecast
7.3.9. Spain
7.3.9.1. Market Size and Forecast
7.3.10. Rest of Europe
7.3.10.1. Market Size and Forecast
7.4. Asia-Pacific Spinal Cord Stimulator Market
7.4.1. Asia-Pacific Market Size & Forecast, By Country
7.4.2. Asia-Pacific Market Size & Forecast, By Type
7.4.3. Asia-Pacific Market Size & Forecast, By Application
7.4.4. Asia-Pacific Market Size & Forecast, By End User
7.4.5. Japan
7.4.5.1. Market Size and Forecast
7.4.6. China
7.4.6.1. Market Size and Forecast
7.4.7. Australia
7.4.7.1. Market Size and Forecast
7.4.8. India
7.4.8.1. Market Size and Forecast
7.4.9. South Korea
7.4.9.1. Market Size and Forecast
7.4.10. Rest of Asia-Pacific
7.4.10.1. Market Size and Forecast
7.5. South America Spinal Cord Stimulator Market
7.5.1. South America Market Size & Forecast, By Country
7.5.2. South America Market Size & Forecast, By Type
7.5.3. South America Market Size & Forecast, By Application
7.5.4. South America Market Size & Forecast, By End User
7.5.5. Brazil
7.5.5.1. Market Size and Forecast
7.5.6. Argentina
7.5.6.1. Market Size and Forecast
7.5.7. Rest of South America
7.5.7.1. Market Size and Forecast
7.6. Middle East & Africa Spinal Cord Stimulator Market
7.6.1. Middle East & Africa Market Size & Forecast, By Country
7.6.2. Middle East & Africa Market Size & Forecast, By Type
7.6.3. Middle East & Africa Market Size & Forecast, By Application
7.6.4. Middle East & Africa Market Size & Forecast, By End User
7.6.5. GCC Countries
7.6.5.1. Market Size and Forecast
7.6.6. Egypt
7.6.6.1. Market Size and Forecast
7.6.7. South Africa
7.6.7.1. Market Size and Forecast
7.6.8. Rest of Middle East & Africa
7.6.8.1. Market Size and Forecast

8. Company Profile
8.1. Medtronic
8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
8.1.2. Medtronic Product Category, Application, and Specification
8.1.3. Medtronic Financial Performance (2016-2018)
8.1.4. Main Business/Business Overview
8.2. Boston Scientific Corp.
8.3. St. Jude Medical
8.4. Nevro Corp
8.5. Nuvectra Corporation
8.6. Saluda Medical PTY Limited
8.7. Greatbatch, Inc.
8.8. NeuroPace
8.9. Synapse Biomedical
8.10. Stimwave